Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine

SIMPLE SUMMARY: Standard treatment with purine analogues facilitates a near normal life expectancy in the majority of patients with classic hairy cell leukemia (HCL), a rare chronic B-cell malignancy. However, nearly all patients ultimately relapse and require retreatment, while drug-induced myeloto...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohn, Jan-Paul, Dietrich, Sascha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869886/
https://www.ncbi.nlm.nih.gov/pubmed/35205704
http://dx.doi.org/10.3390/cancers14040956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869886/
https://www.ncbi.nlm.nih.gov/pubmed/35205704
http://dx.doi.org/10.3390/cancers14040956

Ejemplares similares